Yiwen Li
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 8
- Dialysis and Renal Disease Management 5
- Chronic Kidney Disease and Diabetes 4
- Acute Kidney Injury Research 3
-
- Nitric Oxide and Endothelin Effects 3
-
- Autophagy in Disease and Therapy 4
-
- Atrial Fibrillation Management and Outcomes 2
-
- Eicosanoids and Hypertension Pharmacology 2
- Cited by
- NephrologyCancer ResearchPhysiology
- Journals
- Genes & Development (1 paper)SHILAP Revista de lepidopterología (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yiwen Li
41 papers receiving 832 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Nephrology 207
- Cancer Research 128
- Physiology 158
- Genetics 64
- Molecular Biology 413
Countries citing papers authored by Yiwen Li
This map shows the geographic impact of Yiwen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwen Li more than expected).
Fields of papers citing papers by Yiwen Li
This network shows the impact of papers produced by Yiwen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwen Li. The network helps show where Yiwen Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yiwen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 28 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 26 | |
| 12 | 2019 | 4 | |
| 13 | Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocytebreakdown → | 2019 | 289 |
| 14 | 2018 | 3 | |
| 15 | 2017 | 6 | |
| 16 | 2016 | 13 | |
| 17 | 2015 | 8 | |
| 18 | 2013 | 16 | |
| 19 | 2010 | 2 | |
| 20 | 2009 | 12 |
About Yiwen Li
Yiwen Li is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Transplantation, having authored 48 papers that have together received 839 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (8 papers), Dialysis and Renal Disease Management (5 papers), Chronic Kidney Disease and Diabetes (4 papers), Autophagy in Disease and Therapy (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Acute Kidney Injury Research (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Nephrology (207 citations), Cancer Research (128 citations) and Physiology (158 citations). Yiwen Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qiang He, Jianguang Gong, Juan Jin, Li Zhao, He Huang, Yifen Shi, Juan Jin, Tudor M. Griffith, D. H. Edwards and Roger A. Greenberg. Their work appears in journals such as Genes & Development, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.